Onno Faber is a seasoned entrepreneur, most recently served as the CEO and Co-founder of Rarebase, a platform aimed at accelerating therapeutic discovery for rare genetic disorders. Recognized as one of Worth Magazine's Worthy 100 in 2022, his work centers on leveraging technology and biology to identify potential treatments for rare diseases, a cause close to his heart due to his own diagnosis in 2015.With a strong track record in launching and leading companies across technology, sustainability, and medical research sectors, Faber demonstrates a keen ability to identify and address pressing problems. The companies he co-founded raised $100M in venture funding so far. He's committed to fostering connections between patients and scientists, driving advancements in research for the benefit of all. Based in San Francisco Bay Area, Faber is an inspiring speaker, often sharing his entrepreneurial journey and insights at various global events.